新型生物标志物对心力衰竭预后价值的研究进展

打开文本图片集

【Abstract】Heartfailure（HF）representsthend-stageprogresionofvariousardovasculardiseases，andprogosticaessthas alwaysbeenaiticalfocsoflicalsearh.Altoughraditioabomarkersareidelusedforthagosisandprogosicvauationof HF，theiraccaciprgosticvaluatioilidueuseptibiltttefereefrootrfctors.Intars，easing numberof studieshavebndedicatedtoexploringtheprognosticvalueofovelmarkersinHF.However，clinicaltranslationstilface challengesuettseffeas，cofadddeoesndopifula aplicatiosogoaso.srticleitetatusdttdceetsinicallatiofel biomarkers，to optimize risk stratification and ultimately improve prognosis.

【Keywords】Heart failure;Biomarker;Soluble suppressionof tumorigenicity2;Galectin-3;Prognostic value

心力衰竭（heartfailure，HF）作为多种心血管疾病进展的终末阶段，因其高发病率、高再住院率及不良预后特征已成为全球公共卫生领域亟待解决的重大挑战[1]。（剩余14408字）